Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer

International Braz J Urol

Volumn 36, Issue 1, 2010, Pages 44-48

  Cohen, Jacob H ^a   Eastham, James ^b   Macchia, Richard J ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Neoplasm recurrence; Prostate neoplasms; Prostate specific antigen; Radiation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOPSY; CANCER STAGING; HUMAN; MALE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BIOPSY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77953905428     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382010000100007     Document Type: Article

References (12)

1. Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA: Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer. 2004; 100: 1283-92.
2. Link P, Freiha FS: Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology. 1991; 37: 189-92.
3. No authors listed: Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997; 37: 1035-41.
4. Gaudin PB, Zelefsky MJ, Leibel SA, Fuks Z, Reuter VE: Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol. 1999; 23: 1021-31.
5. Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M: Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys. 2000; 48: 355-67.
6. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Mohan R, Mageras GS, et al.: The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol. 1994; 21: 580-97.
7. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al.: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001; 166: 876-81. Erratum in: J Urol. 2001; 166: 1839.
8. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II: Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002; 54: 677-85.
9. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF: Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol. 1999; 17: 1155.
10. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al.: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006; 65: 965-74.
11. Kuban DA, el-Mahdi AM, Schellhammer P: The significance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys. 1992; 24: 409-14.
12. Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A: Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol. 2008; 179: 1368-73; discussion 1373.